China's Ministries Weigh Controls on 40 Technologies

China on Friday unveiled a draft plan to ban exports of 14 technologies across artificial intelligence, biotechnology and photovoltaic solar power, while placing 26 more under new restrictions. It’s a sweeping proposal. The affected sectors shape decisions about who controls technology, from public health to the pace of the clean-energy transition.

China’s Ministry of Commerce and Ministry of Science and Technology issued the notice jointly. A one-month public consultation on the plan begins Friday.

What Would Be Banned

The draft identifies three categories for outright export bans. One covers AI-driven technology that generates and mutates malicious code, which could make cyberattacks easier to build and harder to stop in the wrong hands. Another covers certain cell and gene therapy technology platforms, medical science that researchers say could change treatment for serious diseases. The third is technology used to produce certain kinds of solar cell modules.

Those are the examples spelled out in the notice. Together, they account for some of the 14 proposed bans across artificial intelligence, biotechnology and photovoltaic solar power. The draft lists another 26 technologies from the same three sectors for new export restrictions, rather than outright bans.

A Public Process, With Limits

The one-month consultation gives the public a chance to comment on the draft before officials finalize anything. That’s a procedural step worth noting. The notice, as described, doesn’t spell out how much weight officials will give the feedback or who will be heard in practice.

The proposal also sets out a tiered approach: the ministries would bar some technologies from leaving the country entirely and place tighter controls on others. Where each technology falls will matter to researchers, manufacturers, governments and patients who rely on what those technologies produce.

Three Sectors, Different Stakes

On the surface, the sectors named in the plan have little in common. Malicious-code AI raises security concerns. Gene therapy platforms affect health and research. Solar cell production touches energy and industry. What links them is the role access to know-how plays in deciding who benefits from advances and who gets left waiting.

As described, the draft doesn’t explain how officials would enforce the restrictions or what exemptions might apply. Those questions are likely to draw scrutiny during the consultation period.

Why This Matters:

Export controls on gene therapy platforms and solar manufacturing technology raise questions that extend well beyond one country’s borders. Gene and cell therapies could affect patients worldwide, while knowledge of solar production is central to how quickly other nations can build cleaner energy systems. Restricting the flow of that technology could slow access for countries and communities with the least capacity to develop it themselves. At the same time, the proposed ban on AI tools that generate and mutate malicious code points to a real security risk that governments of every stripe are wrestling with. This episode highlights a broader tension: technology that serves the public good doesn’t always fit neatly alongside national-security and industrial-policy goals, and individual governments largely set the rules rather than relying on shared international frameworks. The one-month consultation gives those affected a chance to speak up. Whether it changes the outcome remains an open question.